SCHEMBL23976348

SCHEMBL23976348

CC(C)c1cccc(COCCC(Br)C=O)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 3/20 0.38
CTSD P07339 1/20 0.38
MRGPRX4 Q96LA9 1/20 0.35
HDAC4 P56524 2/20 0.34
HDAC8 Q9BY41 2/20 0.34
BCHE P06276 2/20 0.33
CTSB P07858 2/20 0.33
PTGER3 P43115 1/20 0.33
KDM4E B2RXH2 3/20 0.33
TSHR P16473 1/20 0.33
SMN1; SMN2 Q16637 3/20 0.33
HTT P42858 2/20 0.33
ALDH1A1 P00352 2/20 0.33
MDM4 O15151 1/20 0.33
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33
TP53 P04637 1/20 0.33
CYP3A4 P08684 1/20 0.33
MAPT P10636 1/20 0.33
TYR P14679 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23975792 0.79 TSHR (0.47) CTSBTSHRSMN1; SMN2HTTCA1
SCHEMBL5987241 0.76 CTSD (0.51) BACE1CTSDMRGPRX4HDAC4HDAC8
SCHEMBL14001984 0.75 CTSD (0.40) BACE1CTSDMRGPRX4HDAC4HDAC8
SCHEMBL14200520 0.75 CTSD (0.43) BACE1CTSDMRGPRX4HDAC4HDAC8
SCHEMBL26726801 0.73 MRGPRX4 (0.46) BACE1CTSDMRGPRX4BCHEKDM4E
SCHEMBL26723842 0.73 MRGPRX4 (0.43) BACE1CTSDMRGPRX4HDAC4HDAC8
SCHEMBL11509118 0.73 MRGPRX4 (0.41) BACE1CTSDMRGPRX4HDAC4HDAC8
SCHEMBL10154614 0.73 KDM4E (0.41) BACE1CTSDMRGPRX4HDAC4HDAC8
SCHEMBL10121249 0.71 TACR1 (0.43) BACE1CTSDMRGPRX4HDAC4HDAC8
SCHEMBL16919633 0.70 HDAC4 (0.41) BACE1CTSDMRGPRX4HDAC4HDAC8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021222483-A1 METHODS OF USE FOR PYRIMIDINES AS FERROPORTIN INHIBITORS GLOBAL BLOOD THERAPEUTICS, INC. (US) 2021-11-04 WO disclosed